Mk-2461
Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
Grundinformationen
- CAS
917879-39-1- Standard-SMILES
CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1- InChIKey
JGEBLDKNWBUGRZ-HXUWFJFHSA-N- Summenformel
- C24H25N5O5S
- Durchschnittliche Molmasse
- 495,6 g/mol
Überblick
MK-2461 is a member of the class of benzocycloheptapyridines that is 5H-benzo[4,5]cyclohepta[1,2-b]pyridin-5-one substituted by 1-methyl-1H-pyrazol-4-yl and [{[(2R)-1,4-dioxan-2-yl]methyl}(methyl)sulfamoyl]amino groups at positions 3 and 7, respectively. It is a novel ATP-competitive multi-targeted inhibitor of activated c-Met (IC50 = 2.5 nM). It has a role as an antineoplastic agent, an apoptosis inducer and a c-Met tyrosine kinase inhibitor. It is a member of pyrazoles, a member of dioxanes, a benzocycloheptapyridine and a member of sulfamides.
Namen und Bezeichner
- Bevorzugter Name
- Mk-2461
- IUPAC
- 14-[[[(2R)-1,4-dioxan-2-yl]methyl-methylsulfamoyl]amino]-5-(1-methylpyrazol-4-yl)-2-oxo-7-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaene
- Englischer Name
- Mk-2461 .
- Summenformel
- C24H25N5O5S
- Molmasse
- 495.55
Namen und Synonyme
MK-2461917879-39-1MK 2461MK2461UNII-4200RD53XF4200RD53XF9-[[[(2R)-1,4-dioxan-2-yl]methyl-methylsulfamoyl]amino]-2-(1-methylpyrazol-4-yl)-11-oxobenzo[1,2]cyclohepta[2,4-b]pyridineSulfamide, N-((2R)-1,4-dioxan-2-ylmethyl)-N-methyl-N'-(3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo(4,5)cyclohepta(1,2-b)pyridin-7-yl)-Sulfamide, N-[(2R)-1,4-dioxan-2-ylmethyl]-N-methyl-N'-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]-9-((((2R)-1,4-dioxan-2-yl)methyl-methylsulfamoyl)amino)-2-(1-methylpyrazol-4-yl)-11-oxobenzo(1,2)cyclohepta(2,4-b)pyridineRefChem:1591911196681-15-8
Weitere Namen anzeigen
CS-528Mk-2461 .MK-2461 (MK 2461Mk-2461 USP/EP/BPMK-2461, 10 mM in DMSOMK-2461 c-Met HGFR InhibitorN-((2R)-1,4-Dioxan-2-ylmethyl)-N-methyl-N'-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]sulfam
n-((2r)-1,4-dioxan-2-ylmethyl)-n-methyl-n'-[3-(1-methyl-1h-pyrazol-4-yl)-5-oxo-5h-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]sulfamideN-[(2R)-1,4-dioxan-2-ylmethyl]-N-methyl-N'-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]sulfamide14-[[[(2R)-1,4-dioxan-2-yl]methyl-methylsulfamoyl]amino]-5-(1-methylpyrazol-4-yl)-2-oxo-7-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaeneC24H25N5O5SJGEBLDKNWBUGRZ-HXUWFJFHSA-NSCHEMBL93526GTPL7962orb1223655
Eigenschaften
Berechnete StruktureigenschaftenWird ergänzt
- XLogP
- 1,2
- Polarare Oberfläche (TPSA)
- 124 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 9
- Frei drehbare Bindungen
- 6
- Schwere Atome
- 35
- Formalladung
- 0
- Komplexität
- 895
Physikochemische Eigenschaften
- Schmelzpunkt
- 192 · 192-193 °C
- Siedepunkt
- 732.4 · 732.4±70.0 °C(Predicted)
- Dichte
- 1.45 · 1.45±0.1 g/cm3(Predicted)
- storage temp.
- -20 °C · Store at -20°C
- Löslichkeit
- 24.8 mg/mL · ≥24.8 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH
- Aggregatzustand
- solid
- pka
- 6.81 · 6.81±0.20(Predicted)
- Farbe
- Light yellow to yellow
Chemie und Industrie
Anwendungen
VerwendenMK-2461 is a potent inhibitor of c-Met, Ron, Flt1/3, PDGFRβ, Mer and FGFR1/2/3 with IC50 of 2.5 nM, 7 nM, 10 nM/22 nM, 22 nM, 24 nM and 65 nM/39 nM/50 nM, respectively.
Anbieter70 Anbieter
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
南通飞宇生物科技有限公司0513-68819626 15152877458 · [email protected]
武汉英诺医药科技有限公司+86-027-59232304 15387063101 · [email protected]
湖北科乐精细化工有限公司027-59101668 19945030958 · [email protected]
上海凌飞医药科技有限公司13764318709 · [email protected]
大连美仑生物技术有限公司0411-62910999 13889544652 · [email protected]
欧利希（湖北）医药科技有限公司17316404525 17316404525 · [email protected]
InvivoChem中国13549236410 · [email protected]
MedBio脉铂医药021-69568360 18916172912 · [email protected]
北京博奥森生物技术有限公司400-901-9800 18611424007 · [email protected]
MedChemexpress LLC021-58955995 · [email protected]
Zhejiang J&C Biological Technology Co.,Limited+1-2135480471 · [email protected]
Zugehörige Reaktionen
3
Notizen zur Verbindung
Wird geladen…